二氧化碳培養箱市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

2024 年全球二氧化碳培養箱市場價值為 7.927 億美元，預計 2025 年至 2034 年期間的複合年成長率為 5.9%。細胞培養、藥物測試和臨床研究對穩定孵化環境的需求推動了對先進二氧化碳培養箱的需求。公司和研究機構尋求高精度解決方案來維持可靠結果所需的受控條件。新興市場的研發投資不斷擴大、醫療保健基礎設施的進步以及對體外應用的興趣日益濃厚，進一步加速了市場擴張。此外，包括自動化和感測器創新在內的持續技術發展正在提高效率和性能，促進市場持續成長。

二氧化碳培養箱旨在維持生物培養的最佳條件，確保對溫度、濕度和二氧化碳水平的精確控制。根據產品類型，市場包括水套式、空氣套式和直熱式二氧化碳培養箱。 2024 年，水套式二氧化碳培養箱引領市場，創造 3.13 億美元的收入。它們能夠保持一致的溫度調節，這使它們成為長期研究的首選。這些培養箱可減少溫度波動，確保敏感科學應用所需的穩定性。

根據容量，市場分為三個部分：100公升以下，100-200公升，200公升以上。 100-200 公升類別的複合年成長率預計將達到 6.4%，到 2034 年將超過 6.872 億美元。其容量和效率的平衡使其成為跨研究應用的有吸引力的選擇。

在應用方面，市場涵蓋實驗室研究、體外應用和其他科學用途。預計實驗室研究將保持主導地位，以 6.4% 的複合年成長率成長，到 2034 年將超過 7.607 億美元。隨著全球對基因組學、生物技術和再生醫學的興趣日益成長，實驗室需要這些系統來維持生物研究的最佳條件。

感測器技術在維持孵化器內的二氧化碳水平方面發揮著至關重要的作用。市場分為紅外線 (IR) 和熱導 (TC) CO2 培養箱等。紅外線二氧化碳培養箱預計將實現 6.5% 的複合年成長率，到 2034 年將超過 8.636 億美元。

根據最終用途，市場包括生物技術和製藥公司、學術機構和臨床實驗室。生物技術和製藥公司在藥物開發、基因研究和臨床試驗中已廣泛應用，佔 2024 年總收入的 39.3%。

2024 年，美國市場規模達到 1.693 億美元，預計到 2034 年將以 5.6% 的複合年成長率成長，這得益於美國先進的醫療保健行業、研究基礎設施和持續的醫療創新。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 二氧化碳培養箱在細胞培養和幹細胞研究的應用日益廣泛
    • 慢性病盛行率上升及再生醫學需求
    • 孵化器技術的進步
    • 生物製藥和疫苗產量成長
  • 產業陷阱與挑戰
    • 先進的二氧化碳培養箱成本高
• 成長潛力分析
• 監管格局
• 技術格局
• 差距分析
• 波特的分析
• PESTEL 分析
• 未來市場趨勢
• 價值鏈分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2034 年

• 主要趨勢
• 水套二氧化碳培養箱
• 氣套二氧化碳培養箱
• 直熱式二氧化碳培養箱
• 其他產品類型

第6章：市場估計與預測：按產能，2021 - 2034 年

• 主要趨勢
• 100 – 200 公升
• 100公升以下
• 200公升以上

第 7 章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 實驗室研究
• 體外受精（IVF）
• 癌症研究
• 其他應用

第 8 章：市場估計與預測：按感測器技術，2021 - 2034 年

• 主要趨勢
• 紅外線 (IR) CO2 培養箱
• 熱導率 (TC) CO2 培養箱
• 其他感測器技術

第 9 章：市場估計與預測：按最終用途，2021 - 2034 年

• 主要趨勢
• 生物技術和製藥公司
• 學術及研究機構
• 臨床實驗室
• 其他最終用戶

第 10 章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：公司簡介

• avantor
• BINDER
• CARON SCIENTIFIC
• ESCO
• HYLAND
• Labotect
• memmert
• NUAIRE
• phcbi
• SHELDON MANUFACTURING
• Thermo Fisher

The Global Carbon Dioxide Incubators Market was valued at USD 792.7 million in 2024 and is projected to expand at a 5.9% CAGR from 2025 to 2034. Market growth is primarily driven by increasing research activities in biotechnology, pharmaceuticals, and medical sciences. The need for stable incubation environments in cell culture, drug testing, and clinical research is fueling the demand for advanced CO2 incubators. Companies and research institutions seek high-precision solutions to maintain controlled conditions essential for reliable results. Expanding R&D investments in emerging markets, advancements in healthcare infrastructure, and rising interest in in vitro applications are further accelerating market expansion. Additionally, continuous technological developments, including automation and sensor innovations, are enhancing efficiency and performance, contributing to sustained market growth.

Carbon dioxide incubators are designed to maintain optimal conditions for biological cultures, ensuring precise control over temperature, humidity, and CO2 levels. Based on product type, the market includes water jacket, air jacket, and direct heat CO2 incubators. Water jacket CO2 incubators led the market in 2024, generating USD 313 million in revenue. Their ability to maintain consistent temperature regulation makes them a preferred choice for long-term research. These incubators reduce temperature fluctuations, ensuring the stability required for sensitive scientific applications.

By capacity, the market is divided into three segments: below 100 liters, 100-200 liters, and above 200 liters. The 100-200 liters category is projected to experience a 6.4% CAGR, surpassing USD 687.2 million by 2034. This segment dominates due to its versatility in laboratories, providing ample space for multiple culture vessels without requiring excessive room. Its balance of capacity and efficiency makes it an attractive option across research applications.

In terms of application, the market covers laboratory research, in vitro applications, and other scientific uses. Laboratory research is expected to maintain its dominant position, growing at a 6.4% CAGR and exceeding USD 760.7 million by 2034. The rising demand for controlled environments in genetic, microbiological, and cellular research is increasing reliance on CO2 incubators. As global interest in genomics, biotechnology, and regenerative medicine grows, laboratories require these systems to sustain optimal conditions for biological studies.

Sensor technology plays a crucial role in maintaining CO2 levels within incubators. The market is categorized into infrared (IR) and thermal conductivity (TC) CO2 incubators, among others. IR CO2 incubators are anticipated to achieve a 6.5% CAGR, surpassing USD 863.6 million by 2034. Their high accuracy and rapid response capabilities ensure stable conditions for cell cultures, making them the preferred choice in research and medical applications.

By end use, the market includes biotechnology and pharmaceutical companies, academic institutions, and clinical laboratories. Biotechnology and pharmaceutical firms accounted for 39.3% of total revenue in 2024 due to their extensive use in drug development, genetic studies, and clinical trials.

The U.S. market reached USD 169.3 million in 2024 and is expected to grow at a 5.6% CAGR through 2034, driven by its advanced healthcare sector, research infrastructure, and ongoing medical innovations.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing adoption of CO2 incubators in cell culture and stem cell research
    • 3.2.1.2 Rising prevalence of chronic diseases and demand for regenerative medicine
    • 3.2.1.3 Advancements in incubator technology
    • 3.2.1.4 Growth in biopharmaceutical and vaccine production
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced CO2 incubators
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Water jacket carbon dioxide incubators
• 5.3 Air jacket carbon dioxide incubators
• 5.4 Direct heat carbon dioxide incubators
• 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Capacity, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 100 – 200 liters
• 6.3 Below 100 liters
• 6.4 Above 200 liters

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Laboratory research
• 7.3 In vitro fertilization (IVF)
• 7.4 Cancer research
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Sensor Technology, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Infrared (IR) CO2 incubators
• 8.3 Thermal conductivity (TC) CO2 incubators
• 8.4 Other sensor technologies

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Biotechnology and pharmaceutical companies
• 9.3 Academic and research institutions
• 9.4 Clinical laboratories
• 9.5 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 avantor
• 11.2 BINDER
• 11.3 CARON SCIENTIFIC
• 11.4 ESCO
• 11.5 HYLAND
• 11.6 Labotect
• 11.7 memmert
• 11.8 NUAIRE
• 11.9 phcbi
• 11.10 SHELDON MANUFACTURING
• 11.11 Thermo Fisher